Product Document Searching Made Easy by 2D Code! | TCI Chemistry News October 2025 | [TCIPracticalExample] Di-Cbz Guanidinylation of Amine... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
请选择数量
CAS RN: 850140-72-6 | 产品编码: A2870
Afatinib
×
![]()
×
| 产品编码 | A2870 |
纯度/分析方法 
|
>97.0%(HPLC)(N) |
| 分子式/分子量 | C__2__4H__2__5ClFN__5O__3 = 485.94 |
| 外观与形状（20°C） | 固体 |
| 储存温度
|
冷藏 (0-10°C) |
| 应避免的情况 | 加热 |
| 包装和容器
|
250MG-Glass Bottle with Plastic Insert （查看图片）, 50MG-Glass Bottle with Plastic Insert （查看图片） |
| CAS RN | 850140-72-6 |
| Reaxys-RN | 11746023 |
| PubChem物质ID | 468590121 |
| MDL编号 | MFCD12407405 |
技术规格
| Appearance | White to Orange to Green powder to crystal |
| Purity(HPLC) | min. 97.0 area% |
| Purity(with Total Nitrogen) | min. 97.0 % |
| Water | max. 3.0 % |
| NMR | confirm to structure |
物性（参考值）
| 熔点 | 102 °C |
GHS
相关法规
运输信息
| HS编码* | 2934.99-000 |
应用
Afatinib: An Irreversible Inhibitor of the ErbB Family of Tyrosine Kinases
Afatinib (BIBW-2992) is an irreversible inhibitor of the ErbB family of tyrosine kinases. The ErbB receptor tyrosine kinase family consists of four cell surface receptors: ErbB1/EGFR/HER1, ErbB2/HER2, ErbB3/HER3, and ErbB4/HER4. Deregulation of the ErbB receptor network is well recognized as an oncogenic driver in epithelial cancers. Afatinib downregulates ErbB signaling by covalently binding through a Michael addition reaction to the kinase domains of ErbB1/EGFR/HER1, ErbB2/HER2 and ErbB4/HER4, irreversibly inhibiting tyrosine kinase autophosphorylation. Afatinib was approved by FDA for the treatment of EGFR mutated non-small cell lung cancer in 2013. (The product is for research purpose only.)
References
- 1) BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
- 2) Target binding properties and cellular activity of afatinib (BIBW 2992), an irreversible ErbB family blocker
- 3) Afatinib: First Global Approval (a review)
- 4) A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer
产品文档 (部分产品的分析图谱无法提供，敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助，请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注：该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉，您搜索的分析图谱无法提供。